Insilico Medicine logo

    Insilico Medicine

    Paid
    https://insilico.com
    >> OPEN TOOL

    Insilico Medicine is an AI-driven drug discovery company that uses generative AI to design novel drug molecules, identify disease targets, and predict clinical trial outcomes, with a pipeline spanning oncology, fibrosis, and immunology. It has demonstrated industry-leading speed in generating clinical candidates from concept to IND.

    Category

    Healthcare

    Subcategory

    Drug Discovery

    Free Tier

    Not available yet

    Paid Plans

    Pharma partnerships and Pharma.AI platform licensing

    API Cost

    Not available yet

    Web App

    Insilico Medicine Trust & Security Report

    Certifications, AI-training posture, and security controls, with sourced proof.

    VIEW
    GDPR

    Verified against Insilico Medicine's own trust and security pages. See the full report for sourced proof →

    Region

    Multi-region: Primary processing in Hong Kong. Data stored in Seoul (Korea) for cloud.chemistry42.com SaaS, Ireland for lab.chemistry42.com SaaS. Data transfers to and from Hong Kong documented in privacy policy.

    Trains on Data

    Yes

    Self-hostable

    No

    Designing novel small molecule drug candidates with generative AIIdentifying new biological targets for disease treatmentPredicting potential drug candidates for IPF and oncologyAccelerating hit-to-lead optimization in drug discoveryPharmaceutical R&D partnerships for target-specific programs

    // MORE IN DRUG DISCOVERY

    Recursion Pharmaceuticals logoRecursion Pharmaceuticals
    Paid
    HealthcareDrug DiscoveryVerified
    #drug discovery#machine learning
    Numerion Labs logoNumerion Labs
    Paid
    HealthcareDrug DiscoveryVerified
    #drug discovery#molecular modeling
    BenevolentAI logoBenevolentAI
    Paid
    HealthcareDrug DiscoveryVerified
    #drug discovery#knowledge graph